We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Indivior Plc | LSE:INDV | London | Ordinary Share | GB00BN4HT335 | ORD USD0.50 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-6.00 | -0.39% | 1,514.00 | 1,518.00 | 1,525.00 | 1,540.00 | 1,496.00 | 1,540.00 | 517,964 | 16:35:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.09B | 2M | 0.0148 | 1,027.03 | 2.06B |
TIDMINDV
RNS Number : 0142W
Indivior PLC
03 February 2017
Indivior PLC (the 'Company') - Director Declaration
The Board of Indivior PLC announces that Cary Claiborne has stepped down from his role as Chief Financial Officer in order to pursue other opportunities. The Board of Indivior PLC has appointed Mark Crossley to succeed Cary as CFO.
Mark is currently Chief Strategy Officer of Indivior and was previously Finance Director of the Reckitt Benckiser Pharmaceuticals division prior to the demerger.
Cary will assist with the transition over the coming weeks ahead of the scheduled release of Full Year Results on February 22. As part of the transition, we expect that Cary will step down from the Board and will be replaced by Mark in due course.
Shaun Thaxter, Chief Executive Officer of Indivior PLC, paid tribute to Cary's contribution to the Company during his tenure as Chief Financial Officer from 2014-2017:
"Cary joined us to bring public company experience to the demerger process and the establishment of Indivior as a separate, independent, listed company. He has managed through the complexities of the demerger and separation from Reckitt Benckiser, and the set-up of Indivior, including establishing corporate reporting, internal audit, tax, treasury and external audit; he has also overseen the global implementation of SAP. Throughout these many changes, the Company has delivered strong financial performance and provided transparency to our shareholders. We thank Cary for his many contributions to the successful evolution of Indivior so far and wish him well for the next phase of his career."
Mark was appointed to his current position as Chief Strategy Officer in October 2014. He joined the Company in 2012 as the Global Finance Director with responsibilities for Finance, Information Systems and Procurement. Prior to joining Indivior, Mark spent 13 years at Procter & Gamble in various finance leadership roles including Corporate Portfolio, Strategic and Business Planning (Female Beauty), as well as multiple roles in Corporate Treasury and its Baby Care division. He also enjoyed an eight year career with various operational and staff assignments in the United States Coast Guard. Mark graduated from the United States Coast Guard Academy with a BS in Management and Economics, and from Boston College with an MBA. He is a National Association of Corporate Directors Leadership Fellow.
Thaxter continued, "We welcome Mark Crossley to the role of Chief Financial Officer and look forward to benefiting from his experience and knowledge of the business in leading the finance function into the next phase of Indivior's development."
The Company confirms there is no further information to be disclosed pursuant to LR 9.6.13 in connection with Mark Crossley's appointment.
Media Contacts
Tulchan Communications
+44 207 353 4200
Stephen Malthouse
Jonathan Sibun
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCOKNDKNBKDCBK
(END) Dow Jones Newswires
February 03, 2017 08:30 ET (13:30 GMT)
1 Year Indivior Chart |
1 Month Indivior Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions